Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar)

Sara Deola, Bella S. Guerrouahen, Heba Sidahmed, Anjud Al-Mohannadi, Muhammad Elnaggar, Ramaz Elsadig, Essam Mohamed, Goran Petrovski, Massimo Gadina, Adrian Thrasher, Winfried S. Wels, Stephen P. Hunger, Ena Wang, Francesco M. Marincola, Cristina Maccalli, Chiara Cugno

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

New technologies and therapies designed to facilitate development of personalized treatments are rapidly emerging in the field of biomedicine. Strikingly, the goal of personalized medicine refined the concept of therapy by developing cell-based therapies, the so-called "living drugs". Breakthrough advancements were achieved in this regard in the fields of gene therapy, cell therapy, tissue-engineered products and advanced therapeutic techniques. The Advanced Therapies in Healthcare symposium, organized by the Clinical Research Center Department of Sidra Medicine, in Doha, Qatar (October 2017), brought together world-renowned experts from the fields of oncology, hematology, immunology, inflammation, autoimmune disorders, and stem cells to offer a comprehensive picture of the status of worldwide advanced therapies in both pre-clinical and clinical development, providing insights to the research phase, clinical data and regulatory aspects of these therapies. Highlights of the meeting are provided in this meeting report.

Original languageEnglish
Article number276
JournalJournal of Translational Medicine
Volume16
Issue number1
DOIs
Publication statusPublished - 10 Oct 2018

Fingerprint

Qatar
Medicine
Immunology
Delivery of Health Care
Gene therapy
Oncology
Stem cells
Tissue
Cell- and Tissue-Based Therapy
Therapeutics
Pharmaceutical Preparations
Precision Medicine
Hematology
Allergy and Immunology
Research
Genetic Therapy
Stem Cells
Inflammation
Technology

Keywords

  • Autoimmunity
  • Cell therapy
  • Clinical trials
  • Gene therapy
  • Hematology
  • Oncology
  • Personalized medicine
  • Preclinical
  • Stem cells

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Tailoring cells for clinical needs : Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar). / Deola, Sara; Guerrouahen, Bella S.; Sidahmed, Heba; Al-Mohannadi, Anjud; Elnaggar, Muhammad; Elsadig, Ramaz; Mohamed, Essam; Petrovski, Goran; Gadina, Massimo; Thrasher, Adrian; Wels, Winfried S.; Hunger, Stephen P.; Wang, Ena; Marincola, Francesco M.; Maccalli, Cristina; Cugno, Chiara.

In: Journal of Translational Medicine, Vol. 16, No. 1, 276, 10.10.2018.

Research output: Contribution to journalArticle

Deola, Sara ; Guerrouahen, Bella S. ; Sidahmed, Heba ; Al-Mohannadi, Anjud ; Elnaggar, Muhammad ; Elsadig, Ramaz ; Mohamed, Essam ; Petrovski, Goran ; Gadina, Massimo ; Thrasher, Adrian ; Wels, Winfried S. ; Hunger, Stephen P. ; Wang, Ena ; Marincola, Francesco M. ; Maccalli, Cristina ; Cugno, Chiara. / Tailoring cells for clinical needs : Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar). In: Journal of Translational Medicine. 2018 ; Vol. 16, No. 1.
@article{6607810182fb4b169a58f01eda06a9c8,
title = "Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar)",
abstract = "New technologies and therapies designed to facilitate development of personalized treatments are rapidly emerging in the field of biomedicine. Strikingly, the goal of personalized medicine refined the concept of therapy by developing cell-based therapies, the so-called {"}living drugs{"}. Breakthrough advancements were achieved in this regard in the fields of gene therapy, cell therapy, tissue-engineered products and advanced therapeutic techniques. The Advanced Therapies in Healthcare symposium, organized by the Clinical Research Center Department of Sidra Medicine, in Doha, Qatar (October 2017), brought together world-renowned experts from the fields of oncology, hematology, immunology, inflammation, autoimmune disorders, and stem cells to offer a comprehensive picture of the status of worldwide advanced therapies in both pre-clinical and clinical development, providing insights to the research phase, clinical data and regulatory aspects of these therapies. Highlights of the meeting are provided in this meeting report.",
keywords = "Autoimmunity, Cell therapy, Clinical trials, Gene therapy, Hematology, Oncology, Personalized medicine, Preclinical, Stem cells",
author = "Sara Deola and Guerrouahen, {Bella S.} and Heba Sidahmed and Anjud Al-Mohannadi and Muhammad Elnaggar and Ramaz Elsadig and Essam Mohamed and Goran Petrovski and Massimo Gadina and Adrian Thrasher and Wels, {Winfried S.} and Hunger, {Stephen P.} and Ena Wang and Marincola, {Francesco M.} and Cristina Maccalli and Chiara Cugno",
year = "2018",
month = "10",
day = "10",
doi = "10.1186/s12967-018-1652-y",
language = "English",
volume = "16",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Tailoring cells for clinical needs

T2 - Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar)

AU - Deola, Sara

AU - Guerrouahen, Bella S.

AU - Sidahmed, Heba

AU - Al-Mohannadi, Anjud

AU - Elnaggar, Muhammad

AU - Elsadig, Ramaz

AU - Mohamed, Essam

AU - Petrovski, Goran

AU - Gadina, Massimo

AU - Thrasher, Adrian

AU - Wels, Winfried S.

AU - Hunger, Stephen P.

AU - Wang, Ena

AU - Marincola, Francesco M.

AU - Maccalli, Cristina

AU - Cugno, Chiara

PY - 2018/10/10

Y1 - 2018/10/10

N2 - New technologies and therapies designed to facilitate development of personalized treatments are rapidly emerging in the field of biomedicine. Strikingly, the goal of personalized medicine refined the concept of therapy by developing cell-based therapies, the so-called "living drugs". Breakthrough advancements were achieved in this regard in the fields of gene therapy, cell therapy, tissue-engineered products and advanced therapeutic techniques. The Advanced Therapies in Healthcare symposium, organized by the Clinical Research Center Department of Sidra Medicine, in Doha, Qatar (October 2017), brought together world-renowned experts from the fields of oncology, hematology, immunology, inflammation, autoimmune disorders, and stem cells to offer a comprehensive picture of the status of worldwide advanced therapies in both pre-clinical and clinical development, providing insights to the research phase, clinical data and regulatory aspects of these therapies. Highlights of the meeting are provided in this meeting report.

AB - New technologies and therapies designed to facilitate development of personalized treatments are rapidly emerging in the field of biomedicine. Strikingly, the goal of personalized medicine refined the concept of therapy by developing cell-based therapies, the so-called "living drugs". Breakthrough advancements were achieved in this regard in the fields of gene therapy, cell therapy, tissue-engineered products and advanced therapeutic techniques. The Advanced Therapies in Healthcare symposium, organized by the Clinical Research Center Department of Sidra Medicine, in Doha, Qatar (October 2017), brought together world-renowned experts from the fields of oncology, hematology, immunology, inflammation, autoimmune disorders, and stem cells to offer a comprehensive picture of the status of worldwide advanced therapies in both pre-clinical and clinical development, providing insights to the research phase, clinical data and regulatory aspects of these therapies. Highlights of the meeting are provided in this meeting report.

KW - Autoimmunity

KW - Cell therapy

KW - Clinical trials

KW - Gene therapy

KW - Hematology

KW - Oncology

KW - Personalized medicine

KW - Preclinical

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=85054778126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054778126&partnerID=8YFLogxK

U2 - 10.1186/s12967-018-1652-y

DO - 10.1186/s12967-018-1652-y

M3 - Article

C2 - 30305089

AN - SCOPUS:85054778126

VL - 16

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

IS - 1

M1 - 276

ER -